Volume 62, Issue 6 pp. 1476-1493
RESEARCH PAPER
Open Data

The area between ROC curves, a non-parametric method to evaluate a biomarker for patient treatment selection

Yoann Blangero

Corresponding Author

Yoann Blangero

Service de Biostatistique, Pôle Santé Publique, Hospices Civils de Lyon, Lyon, France

Université de Lyon, Université Lyon 1, CNRS, Laboratoire de Biométrie et Biologie Evolutive UMR 5558, Villeurbanne, France

Correspondence

Yoann Blangero, Service de Biostatistique, Pôle Santé Publique, Hospices Civils de Lyon, Lyon 69003, France.

Email: [email protected]

Search for more papers by this author
Muriel Rabilloud

Muriel Rabilloud

Service de Biostatistique, Pôle Santé Publique, Hospices Civils de Lyon, Lyon, France

Université de Lyon, Université Lyon 1, CNRS, Laboratoire de Biométrie et Biologie Evolutive UMR 5558, Villeurbanne, France

Search for more papers by this author
Pierre Laurent-Puig

Pierre Laurent-Puig

Université Paris Descartes, Sorbonne Paris Cité, Paris, France

Service de génétique, Hôpital Européen Georges Pompidou, Paris, France

INSERM UMR-S 1147, Paris, France

Search for more papers by this author
Karine Le Malicot

Karine Le Malicot

Fédération Francophone de Cancérologie Digestive, Dijon, France

Search for more papers by this author
Côme Lepage

Côme Lepage

Fédération Francophone de Cancérologie Digestive, Dijon, France

Hépato-gastroentérologie et cancérologie digestive, Centre hospitalier universitaire Dijon Bourgogne, Dijon, France

INSERM U 866, Dijon, France

Search for more papers by this author
René Ecochard

René Ecochard

Service de Biostatistique, Pôle Santé Publique, Hospices Civils de Lyon, Lyon, France

Université de Lyon, Université Lyon 1, CNRS, Laboratoire de Biométrie et Biologie Evolutive UMR 5558, Villeurbanne, France

Search for more papers by this author
Julien Taieb

Julien Taieb

Université Paris Descartes, Sorbonne Paris Cité, Paris, France

Chirurgie digestive générale et cancérologique, Hôpital Européen Georges Pompidou, Paris, France

Search for more papers by this author
Fabien Subtil

Fabien Subtil

Service de Biostatistique, Pôle Santé Publique, Hospices Civils de Lyon, Lyon, France

Université de Lyon, Université Lyon 1, CNRS, Laboratoire de Biométrie et Biologie Evolutive UMR 5558, Villeurbanne, France

Search for more papers by this author
First published: 28 April 2020
Citations: 5

Abstract

Treatment selection markers are generally sought for when the benefit of an innovative treatment in comparison with a reference treatment is considered, and this benefit is suspected to vary according to the characteristics of the patients. Classically, such quantitative markers are detected through testing a marker-by-treatment interaction in a parametric regression model. Most alternative methods rely on modeling the risk of event occurrence in each treatment arm or the benefit of the innovative treatment over the marker values, but with assumptions that may be difficult to verify. Herein, a simple non-parametric approach is proposed to detect and assess the general capacity of a quantitative marker for treatment selection when no overall difference in efficacy could be demonstrated between two treatments in a clinical trial. This graphical method relies on the area between treatment-arm-specific receiver operating characteristic curves (ABC), which reflects the treatment selection capacity of the marker. A simulation study assessed the inference properties of the ABC estimator and compared them with other parametric and non-parametric indicators. The simulations showed that the estimate of the ABC had low bias, power comparable to parametric indicators, and that its confidence interval had a good coverage probability (better than the other non-parametric indicator in some cases). Thus, the ABC is a good alternative to parametric indicators. The ABC method was applied to data of the PETACC-8 trial that investigated FOLFOX4 versus FOLFOX4 + cetuximab in stage III colon adenocarcinoma. It enabled the detection of a treatment selection marker: the DDR2 gene.

CONFLICT OF INTEREST

The authors have declared no conflict of interest.

Open Research Badges

Open Data

This article has earned an Open Data badge for making publicly available the digitally-shareable data necessary to reproduce the reported results. The data is available in the Supporting Information section.

This article has earned an open data badge “Reproducible Research” for making publicly available the code necessary to reproduce the reported results. The results reported in this article could fully be reproduced.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.